期刊文献+

原发性T1G3膀胱癌复发后病理分级减低现象的临床意义

Grade regression after recurrence in primary T1G3 bladder cancer
原文传递
导出
摘要 目的 探讨原发性T1G3膀胱癌复发后病理分级减低现象的临床意义。方法 回顾性分析1995年至2004年收治55例原发性T1G3膀胱癌患者的临床资料。55例首次手术方法均采取经尿道膀胱肿瘤电切术,术后均出现复发,次数1~9次。依据复发后是否发生病理分级减低分为2组:A组21例(38.2%),复发后有病理分级减退现象;B组34例(61.8%),复发后病理级别不变。对2组患者性别、年龄、肿瘤大小、是否多发、术后是否膀胱灌注、复发后肿瘤是否浸润肌层、肿瘤病理分级改变以及无瘤生存期等资料进行对比分析。结果 A组原发肿瘤直径〉3cm者9.5%(2/21),复发后肿瘤肌层浸润者23.8%(5/21);而B组分别为38.2%(13/34)和52.9%(18/34),2组差异有统计学意义(P=0.020,0.033)。2组患者5年无瘤生存率分别为(66.8±16.6)%和(50.5±12.9)%,差异有统计学意义(P=0.038)。Cox多因素回归分析显示,病理分级减退现象为影响生存率的独立指标(P=0.044)。结论 原发性T1G3膀胱癌患者复发后病理分级减低者预后相对较好,复发后病理分级减低可作为判断预后的独立因素。 Objective To evaluate the phenomenon of grade regression after recurrence in primary stage T1 Grade 3 bladder cancer. Methods Fifty-five cases of primary stage T1 Grade 3 bladder cancer were treated by transurethral resection of the bladder tumor (TURBT) between 1995 and 2004. All cases got recurrence, varying from 1-9 times. Two groups were divided by grade regression after recurrence. Twenty-one cases (38.2%), group A, got grade regression after recurrence, while group B consisted of 34 cases (61.8%) with no grade regression. Clinical data were analyzed statistically, including sex, age, tumor size, tumor multiplicity, intravesical instillation, muscle invasion, pathological grade alteration and disease free survival. Results Patients of group A had less tumor size 〉3 cm 9.5%(2/21) and muscle invasion 23.8%(5/21) than those of group B, 38.2%(13/ 34) and 52.9% (18/34), respectively (P=0. 020,0. 033). The five-year disease-free survival rates of two groups were 66.8%o and 50.5%0, respectively. Grade regression group had higher survival rate than non-regression group(P = 0. 038). In COX regression analysis, grade regression was the independent predictor for recurrence-free survival (P= 0. 044). Conclusions Patients could have better prognosis with grade regression after recurrence in primary stage Ta Grade 3 bladder cancer. And grade regression coule be an independent variable to predict the prognosis.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2007年第4期260-263,共4页 Chinese Journal of Urology
关键词 膀胱肿瘤 预后 生存分析 Bladder neoplasms Prognosis Survival analysis
  • 相关文献

参考文献12

  • 1Borhan A, Reeder JE, O'Connell MJ, et al. Grade progression and regression in recurrent urothelial cancer. J Urol,2003,169:2106-2109.
  • 2Borden LS Jr, Clark PE, Hall MC. Bladder cancer. Curr Opin Oncol, 2005,17,275-280.
  • 3Lebret T, Gaudez F, Herve JM,et al. Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours:recurrence, progression and success. Eur Urol, 1998,34:67-72.
  • 4Thalmann GN, Markwalder R, Shahin O, et al Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol, 2004,172 : 70-75.
  • 5Kwak C, Ku JH, Park JY, et al. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol,2004,171:149-152.
  • 6杨晓峰,申鹏飞,亢全寅,齐范,米振国,刘红耀,张彦刚,赵小昆.复发性膀胱移行细胞癌10年随访结果分析[J].中华泌尿外科杂志,1998,19(9):530-533. 被引量:12
  • 7Soloway MS. Managing superficial bladder cancer: an overview. Urology, 1992,40 (Suppl) : 5-10.
  • 8曾福华,杨土保,江勃年,刘志红,谭春祈,韩惟青,李俊军,杜兴.原发浅表性膀胱癌预后影响因素分析[J].中华泌尿外科杂志,2004,25(10):669-672. 被引量:18
  • 9张军,曾荔,李贵忠,杨新宇,夏同礼,那彦群,郭应禄.膀胱移行细胞癌T1期复发的多因素分析[J].中华肿瘤杂志,2003,25(5):475-477. 被引量:18
  • 10Sriprasad SI, Hopster D, Muir GH, et al. The biological characteristics of pT1G3 bladder tumours are the same as muscle invasive cancer: a study of cell proliferation and molecular markers of aggressiveness. J Urol, 2001,165 (Supple) : 192.

二级参考文献21

  • 1魏东,王军,王建业,邵鸿勋.表浅性膀胱肿瘤的预后[J].中华泌尿外科杂志,1996,17(5):273-275. 被引量:6
  • 2孙光,马腾骧,王文成.复发性膀胱癌生物学行为的临床分析[J].中华泌尿外科杂志,1996,17(4):199-202. 被引量:11
  • 3Serth J, Kuczyk MA, Bokemeyer C, et al. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer, 1995. 71 : 201-205.
  • 4Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol, 1995, 121 : 303-306.
  • 5Shariat SF, Pahlavan S, Baseman AG, et al. E-cadlherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.Urology, 2001, 57: 60-65.
  • 6Zhang HT, Craft P, Scott PA, etal. Enhancement of tumor growth and vascularity by transfection of vascular endothelial growth factor into MCF-7 cells breast carcinoma cells. J Nail Cancer Inst, 1995, 87: 213-219.
  • 7Chow NH, Liu HS, Chan SH, et al. Expression of vascular endolhelial growth factor in primary superficial bladder cancer. Anticancer Res,1999. 19: 4593-4597.
  • 8Pycha A, Mian C, Hoibauer J, et al. Multifocality of transitional cellcarcinoma results from genetic instability of entire transitional epithelium.Urology, 1999, 53: 92-97.
  • 9Andres RA, Salvador PF, Joaquin GG, et al. Multivariate analysis of survival recurrence progression and development d metastasis in T1 andT2a Transitional Cell Bladder Carcinoma. Cancer, 2002.94: 1677-1684.
  • 10Allard P, Bemard P, Frader Y, et al. The early clinical course of primary Ta and T1 bladder cancer : a proposed prognostic indet. Br J Urol, 1998, 81: 692-698.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部